Mednet Logo
HomeMedical OncologyQuestion

In clinically metastatic lung cancer with bone predominant disease, do you routinely biopsy the bone to prove metastatic involvement, knowing that bone biopsies are generally not ideal for molecular testing?

3 Answers
Mednet Member
Mednet Member
Medical Oncology · Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

If patients have diffuse disease, I do not biopsy bone lesions to confirm bone involvement if imaging studies are very suggestive. I do refer patients with an otherwise local or locoregional disease with bone lesion that is suspicious, since that would change the stage and management.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · The Ohio State University School of Medicine

In general, I do try to prove metastatic disease especially if this is initial diagnosis or in the setting of disease recurrence after curative treatment. If you plan ahead and discuss with your pathologist, sometimes they can change the processing to allow for DNA testing though this might not be a...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · Emory University School of Medicine

I try to prove metastatic disease pathologically at initial diagnosis or in the setting of disease recurrence after curative treatment. If the bone lesions are the only site of mets, I discuss with radiology to biopsy the bony lesion with soft tissue, if possible, to send to NGS. If no soft tissue a...

Register or Sign In to see full answer